| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.81 | 0.001 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.46 | 0.09 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.29 | 0.6 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.12 | 0.7 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.5 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.074 | 0.2 |